Find a product

Find Generic

Linadus®

Linagliptin

Description:
Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor.
Indications:
Type-2 diabetes.
Mode of Action:
Linagliptin increases the secretion of insulin from beta cell & decreases hepatic glucose overproduction by inhibiting DPP-4 enzyme & increasing the level of incretin hormones like glucagon-like peptide:1 (GLP-1) & glucose insulinotropic polypeptide (GIP).

Different Dosages from Linadus

Other Brands From Same Therapeutic Class